Top Hat headlines another slew of #CDNtech C-suite changes
Plus: Might we interest you in some CEBA refinancing options?
layoffs
Requity Homes secures $26 million for rent-to-own platform as high interest rates loom over prospective homeowners
Requity aims to help renters become homeowners in markets outside of Toronto and Vancouver.
Clinia secures Series A funding, partnership with Telus Health to deploy its search tech
CEO says endorsement from Canada’s largest healthtech player gives Clinia “visa” it needs to catch big US fish.
S|W: The SaaS Weekly – Constellation Software scoops up Conduent subsidiaries for $260M USD
Plus: After 10 years leading Tulip, Ali Asaria steps down as CEO.
BenchSci trims headcount citing generative AI, economic conditions
BenchSci confirmed to BetaKit that it laid off 17 percent of its workforce.
What’s Mike Katchen’s New Year’s resolution?
Plus: A number of #CDNtech executive changes around the holidays.
After 10 years leading Tulip, Ali Asaria steps down as CEO
Tulip COO and president Ian Rawlins to replace Asaria.
R|T: The Retail Times – Etsy and Bolt make cuts as revenue growth dips
Plus: Leav closes seed round for mobile self-checkout.
A|I: The AI Times – Critics skewer Fed’s AI consultations, Cohere co-founder wants to keep it simple
Startup founded by ex-Google Search team nears $2 billion valuation.
S|W: The SaaS Weekly – BlackBerry names new CEO, ditches spinout IPO plans
Plus: Vistara Growth Fund V sets target on enterprise software companies.
Montréal’s tech hub is in trouble, Waterloo Region goes grassroots
Plus: Why is the Start-up Visa program struggling?
Vistara Growth secures $200-million CAD initial close for fifth private credit fund
Vistara sees opportunity post-SVB as bank lenders, VCs pull back.
S|W: The SaaS Weekly – Why did SaaS VC stalwart OpenView shut down?
Plus: ContactMonkey secures $55-million Series A.
Cultivator has a new leader, Canadian FinTech leader has some new capital
Plus: Meet BetaKit’s new newsletter editor.
H|T: The Healthtech Times – New Spring Impact Capital fund targets early-stage healthtech startups
Plus: AbCellera decimates staff in biotech slump.